Profusa (PFSA) CFO converts $1.29M note into 302K shares at $4.28
Profusa (PFSA) CFO Fred Knechtel converted a $1.29M note into 302K shares at $4.28 each, following a 1-for-4 reverse stock split. The conversion occurred on August 12, 2026, under a Note Modification and Conversion Agreement. Knechtel, through NorthView Sponsor I LLC, now indirectly holds 302K shares.
How this was made
The 30-second read
Why it matters
The transaction modestly increases insider holdings while slightly diluting existing shareholders; likely minimal price movement.
Market read
Primary disclosure of an insider conversion; relevance limited to PFSA investors.
What to watch
Potential future financing needs if cash burn remains high.
Background
Form 4 filing discloses insider conversion of a convertible promissory note into common stock after a 1‑for‑4 reverse split.
Ticker impact
CFO converted a $1.29M convertible note into 301,991 post‑split shares, increasing insider-held stock and diluting existing shareholders.
Minor downward pressure due to dilution, offset by insider confidence.
Conversion size is small relative to market cap; insider stake remains minimal.
Market effects
Limited; reflects typical micro‑cap financing activity.
None
None
Counterpoint
The dilution could be viewed as a negative catalyst for short‑term traders.
Key entities
- CompanyProfusa, Inc.
Micro‑cap biotech listed on NASDAQ under PFSA.
- ExecutiveFred S. Knechtel
Chief Financial Officer of Profusa, acting as manager of NorthView Sponsor I LLC.